P450
Products for P450
- Cat.No. Product Name Information
- GC41128 5(S),6(R)-11-trans DiHETE 5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE that is formed by the enzymatic isomerization of 5(S),6(R)-DiHETE by a membrane bound factor.
- GC61814 5,7-Dimethoxyflavone 5,7-Dimethoxyflavone is one of the major components of Kaempferia parviflora, has anti-obesity, anti-inflammatory, and antineoplastic effects.
- GC42546 5-hydroxy Diclofenac 5-hydroxy Diclofenac is a metabolite of the NSAID diclofenac formed by the cytochrome P450 (CYP) isoform CYP3A4.
-
GC41312
5-hydroxy Omeprazole
5-hydroxy Omeprazole is a major metabolite of omeprazole, an inhibitor of the gastric H+/K+-ATPase pump.
- GC42550 5-hydroxy-6-methoxy (S)-Duloxetine 5-hydroxy-6-methoxy (S)-Duloxetine is a metabolite of (S)-duloxetine.
- GC42551 5-hydroxymethyl Tolterodine (formate) 5-hydroxymethyl Tolterodine is an active metabolite of the muscarinic acetylcholine receptor antagonists tolterodine and fesoterodine.
- GC42586 6α-hydroxy Paclitaxel 6α-hydroxy Paclitaxel is a primary metabolite of the anticancer compound paclitaxel, produced by the action of the cytochrome P450 isoform CYP2C8.
- GC45969 6β-hydroxy Eplerenone A major metabolite of eplerenone
- GC49629 6β-hydroxy Prednisolone A metabolite of prednisolone
- GC41302 6',7'-Epoxybergamottin 6'7'-Epoxybergamottin is a furanocoumarin found in grapefruit.
-
GC42580
6-hydroxy Chlorzoxazone
6-hydroxy Chlorzoxazone is a metabolite of chlorzoxazone.
- GC18219 6-hydroxy Warfarin 6-hydroxy Warfarin is a metabolite of (+)-warfarin , which is a weaker vitamin K antagonist than (-)-warfarin .
- GC49429 6-keto Lithocholic Acid A metabolite of lithocholic acid
- GC42584 6-O-desmethyl Donepezil 6-O-desmethyl Donepezil is an active metabolite of the acetylcholinesterase inhibitor donepezil.
- GC18335 6β-hydroxy Dexamethasone 6β-hydroxy Dexamethasone is a metabolite of dexamethasone that is more hydrophilic than the parent compound.
- GC52062 7-Benzyloxy-4-(trifluoromethyl)coumarin A fluorogenic substrate for CYP1A2 and CYP3A
- GC49320 7-Ethoxy-4-(trifluoromethyl)coumarin A fluorogenic substrate for CYPs
- GC49030 7-Ethoxycoumarin A CYP450 substrate
- GC40572 7-keto Cholesterol A bioactive sterol and a major oxysterol component of oxidized LDL
-
GC46241
7-keto Cholesterol-d7
7-keto Cholesterol is a bioactive sterol and a major oxysterol component of oxidized LDL
- GC35201 8-Geranyloxypsoralen 8-Geranyloxypsoralen is a furanocoumarin isolated from grapefruit, acts as a potent inhibitor of P450 3A4 (CYP3A4) with an IC50 of 3.93 μM.
- GC42626 8-hydroxy Efavirenz 8-hydroxy Efavirenz is a major oxidative metabolite of the non-nucleoside reverse transcriptase inhibitor efavirenz.
- GC18654 8-hydroxy Loxapine 8-hydroxy Loxapine (8-OH loxapine) is a metabolite formed when loxapine , an atypical antipsychotic, is metabolized by the cytochrome P450 isoform CYP1A2.
- GC49544 8-hydroxy Mirtazapine A metabolite of mirtazapine
- GC40464 9(R)-HETE 9(R)-HETE is an enantiomer which makes up 50% of (±)9-HETE.
- GC40465 9(S)-HETE 9(S)-HETE is an enantiomer which makes up 50% of (±)9-HETE.
- GC63469 Abiraterone-D4 Abiraterone-D4 (CB-7598-D4) is the deuterium labeled Abiraterone. Abiraterone is a potent and irreversible CYP17A1 inhibitor with antiandrogen activity, which inhibits both the 17α-hydroxylase and 17,20-lyase activity of the cytochrome p450 enzyme CYP17 with IC50s of 2.5 nM and 15 nM, respectively.
- GC14781 ABT (1-Aminobenzotriazole) ABT (1-Aminobenzotriazole) is a nonspecific and irreversible inhibitor of cytochrome P450 (P450).
- GC35236 Acetylshikonin Acetylshikonin, derived from the root of Lithospermum erythrorhizon, has anti-cancer and antiinflammation activity.
- GC40638 Alclometasone Dipropionate Alclometasone dipropionate (ACM) is a corticosteroid.
- GC18539 all-trans-4-hydroxy Retinoic Acid all-trans-4-hydroxy Retinoic acid is a metabolite of all-trans retinoic acid formed by the cytochrome P450 (CYP) isoforms CYP26A1, B1, and C1.
- GC46835 Alyssin An isothiocyanate with diverse biological activities
- GC46842 Amiodarone-d4 (hydrochloride) An internal standard for the quantification of amiodarone
- GC31141 Antihistamine-1 Antihistamine-1 is a H1-antihistamine (Ki=6.9 nM) with acceptable blood-brain barrier penetration and also an inhibitor of CYP2D6 and hERG channel with IC50s of 5.4 and 0.8 μM, respectively.
- GC52024 Aripiprazole N-oxide A metabolite of aripiprazole
- GC61574 AS1810722 AS1810722 is an orally active and potent STAT6 inhibitor with an IC50 of 1.9 nM.
- GC49421 Atorvastatin lactone-d5 An internal standard for the quantification of atorvastatin lactone
- GC65088 Atovaquone-d5
- GC42878 Avanafil metabolite M16 Avanafil metabolite M16 is a major inactive metabolite of the phosphodiesterase 5 (PDE5) inhibitor avanafil.
- GC42879 Avanafil metabolite M4 Avanafil metabolite M4 is a major active metabolite of the phosphodiesterase 5 (PDE5) inhibitor avanafil.
- GC42887 Axitinib Sulfoxide Axitinib sulfoxide is a major inactive metabolite of the tyrosine kinase inhibitor axitinib.
-
GC42888
Azamulin
Azamulin is a selective, irreversible inhibitor of cytochrome P450 (CYP) 3A isoforms (IC50 values range from 26 to 240 nM for CYP3A4 and CYP3A4/5 from different sources).
- GC49403 Benzarone An active metabolite of benzbromarone
- GC34132 Bergamottin (5-Geranoxypsoralen) Bergamottin (5-Geranoxypsoralen) is a potent and competitive CYP1A1 inhibitor with a Ki of 10.703 nM.
- GC33909 Bergaptol (5-Hydroxypsoralen) Bergaptol (5-Hydroxypsoralen) is a hydroxylated psoralen that acts as a potent inhibitors of debenzylation activity of CYP3A4 enzyme with an IC50 value of 24.92 uM.
- GC65345 BI 653048 BI 653048 is a selective and orally active nonsteroidal?glucocorticoid (GC)?agonist with an IC50 value of 55 nM.
- GC32419 BI 689648 BI 689648 is a novel, highly selective aldosterone synthase inhibitor which can inhibit CYP11B1 and CYP11B2 with IC50s of 310 and 2.1 nM, respectively.
- GC46933 Bitertanol A triazole fungicide
- GC31479 BMS-819881 BMS-819881 is a melaninconcentrating hormone receptor 1 (MCHR1) antagonist, which binds rat MCHR1 with a Ki of 7 nM.
- GC62491 BMS-986202 BMS-986202 is a potent, selective and orally active Tyk2 inhibitor that binds to Tyk2 JH2 with an IC50 of 0.19 nM and a Ki of 0.02 nM.
- GC45887 Bufuralol-d9 (hydrochloride) An internal standard for the quantification of bufuralol
- GC32257 Carbosulfan Carbosulfan inhibited relatively potently CYP3A4 and moderately CYP1A1/2 and CYP2C19 in pooled HLM (human livers).
- GC47040 Carebastine-d5 An internal standard for the quantification of carebastine
- GC41264 CAY10434 20-HETE is an important metabolite of arachidonic acid in the vasculature, especially in the kidney, where it is synthesized by cytochrome P450 (CYP450) enzymes of the 4A family.
- GC43158 CAY10462 20-HETE is an important metabolite of arachidonic acid in the vasculature, especially in the kidney, where it is synthesized by cytochrome P450 (CYP450) enzymes of the 4A family.
- GC18879 CAY10662 17(R),18(S)-Epoxyeicosatetraenoic acid (17(R),18(S)-EpETE), a natural cytochrome P450 epoxygenase metabolite of eicosapentaenoic acid, is known to reduce the contraction rate of spontaneously beating heart cells and to protect neonatal rat cardiomyocytes against arrhythmias induced by β-adrenergic agonists (EC50 = ~ 1-2 nM).
- GC18698 CAY10665 Isolated neonatal rat cardiomyocytes, which spontaneously beat in culture, are used to evaluate the antiarrhythmic effects of polyunsaturated fatty acids (PUFA).
- GC47064 CAY10770 An inhibitor of CYP4Z1
- GC31464 CDD3505 CDD3505 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.
- GC31460 CDD3506 CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.
- GC32991 Cecropin B Cecropin B has high level of antimicrobial activity and is considered as a valuable peptide antibiotic.
- GC38681 Cedrol A sesquiterpene alcohol
- GC16751 Chlorzoxazone Muscle-relaxing drug
- GC35692 Chrysosplenetin A flavonoid with diverse biological activities
- GC43278 Clindamycin Sulfoxide Clindamycin sulfoxide is an active metabolite of the antibiotic clindamycin.
- GC38758 Clomethiazole Chlormethiazole is an potent and orally active GABAA?agonist.
- GC49096 Cobaltic Protoporphyrin IX (chloride) An inducer of HO-1 activity
- GC47118 Colchicoside A glycoside form of 3-demethylcolchicine
- GC49146 Colupulone A β-acid with diverse biological activities
- GC41611 Curcumenol Curcumenol is a sesquiterpene that has been found in Curcuma species.
- GC49410 CVT-2738 An active metabolite of ranolazine
- GC35788 CYP17-IN-1 CYP17-IN-1 (compound 9c) is a potent and orally active CYP17 inhibitor against rat and human CYP17 with IC50s of 15.8 and 20.1 nM.
- GC35803 Dafadine-A Dafadine-A, an analog of dafadine, is a novel inhibitor of DAF-9 cytochrome P450 in the nematode Caenorhabditis elegans; also inhibits the mammalian ortholog of DAF-9(CYP27A1).
- GC62304 Dapaconazole Dapaconazole, as an antifungal agent, inhibits sterol 14α-demethylase cytochrome P450 activity with an IC50 of 1.4 μM.
- GC43400 Dehydro Aripiprazole (hydrochloride) Dehydro aripiprazole is the primary, active metabolite of aripiprazole, an atypical antipsychotic.
- GC43401 Dehydro Nifedipine Dehydro nifedipine is an active metabolite of nifedipine, a calcium channel blocker present in formulations used to treat hypertension and angina.
- GC45650 Des(benzylpyridyl) Atazanavir A metabolite of atazanavir
- GC47193 Desethyl Hydroxychloroquine-d4 An internal standard for the quantification of desethyl hydroxychloroquine
- GC47195 Desethylchloroquine-d4 An internal standard for the quantification of desethylchloroquine
- GC49202 Desmethyl Mirtazapine (hydrochloride) A metabolite of mirtazapine
- GC49409 Desmethyl Ranolazine A metabolite of ranolazine
- GC52038 Desthiazolylmethyl Ritonavir A ritonavir degradation product
- GC18252 Diallyl Sulfide An organosulfur compound
-
GC43440
Dibenzylfluorescein
Dibenzylfluorescein is a fluorogenic probe that acts as a substrate for specific cytochrome P450 (CYP) isoforms, including CYP3A4, CYP2C8, CYP2C9, CYP2C19, and aromatase (CYP19).
- GC30479 Dihydromethysticin ((+)-Dihydromethysticin) Dihydromethysticin ((+)-Dihydromethysticin) is one of the six major kavalactones found in the kava plant; has marked activity on the induction of CYP3A23.
- GC16550 Diosmetin CYP1A1 inhibitor
- GC47234 Diosmetin-d3 An internal standard for the quantification of diosmetin
- GC19415 DMU2105 DMU2105 is a potent and specific CYP1B1 inhibitor, with IC50s of 10 nM and 742 nM for CYP1B1 and CYP1A1, respectively.
- GC19416 DMU2139 DMU2139 is a potent and specific CYP1B1 inhibitor, with IC50s of 9 nM and 795 nM for CYP1B1 and CYP1A1, respectively.
- GC49288 Dolutegravir M1 A metabolite of dolutegravir
- GC12892 Doxepin (hydrochloride) histamine, serotonin, adrenergic, and muscarinic receptors antagonist
- GC60791 Doxepin D3 Hydrochloride Doxepin D3 Hydrochloride is a deuterium labeled Doxepin Hydrochloride.
- GC65260 EDP-305 EDP-305 is an orally active, potent and selective farnesoid X receptor (FXR) agonist, with EC50 values of 34 nM (chimeric FXR in CHO cells) and 8 nM (full-length FXR in HEK cells).
- GC35981 EMT inhibitor-2 EMT inhibitor-2 (Compound 1) inhibits epithelial-mesenchymal transition (EMT) induced by substances such as IL-1β and TGF-β released from the immunocytes.
- GC43621 Epoxy Fluor 7 Soluble epoxide hydrolase (sEH) catalyzes the conversion of epoxyeicosatrienoic acids (EpETrEs) to the corresponding DiHETrEs thereby diminishing their vasodilator activity.
- GC43626 Erythromycin A N-oxide Erythromycin A N-oxide is a potential impurity found in commercial preparations of erythromycin.
- GC43627 Erythromycin lactobionate A macrolide antibiotic
-
GC12250
Fenofibrate
PPARα agonist
- GC49230 Ferroprotoporphyrin Ferroprotoporphyrin, a complex of ferrous iron and a porphyrin, is an isosteric inhibitor of fatty acid binding to rat liver fatty acid binding protein.
- GC60167 Fipronil An insecticide